🇪🇺 Alimta in European Union

EMA authorised Alimta on 20 September 2004

Marketing authorisation

EMA — authorised 20 September 2004

  • Marketing authorisation holder: ELI LILLY NEDERLAND B.V.
  • Status: approved

Alimta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Alimta approved in European Union?

Yes. EMA authorised it on 20 September 2004.

Who is the marketing authorisation holder for Alimta in European Union?

ELI LILLY NEDERLAND B.V. holds the EU marketing authorisation.